Pacer Advisors
CLVS

Pacer Advisors’s Clovis Oncology, Inc. CLVS Stock Holding History

Pacer Advisors’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-13,131
Closed -$92K – 1593
2021
Q1 		$92K Sell
13,131
-14,158
-52% -$94.9K ﹤0.01% 1306
2020
Q4 		$131K Buy
27,289
+11,738
+75% +$59.4K ﹤0.01% 1317
2020
Q3 		$91K Buy
+15,551
New +$93K ﹤0.01% 1263
2018
Q4 		– Sell
-7,688
Closed -$226K – 1110
2018
Q3 		$226K Buy
+7,688
New +$298K 0.01% 1009
2018
Q1 		– Sell
-1,657
Closed -$113K – 1146
2017
Q4 		$113K Sell
1,657
-6,137
-79% -$429K 0.01% 952
2017
Q3 		$642K Buy
+7,794
New +$618K 0.06% 531

Other funds holding CLVS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Pacer Advisors's CLVS Position: Q2 2021 in Review

Pacer Advisors sold out of Clovis Oncology, Inc. (CLVS) in Q2 2021, closing a stake of 13,131 shares — an estimated $92K sold.

Pacer Advisors first reported a position in CLVS in Q3 2017 and held it in 6 quarters. The position peaked at $642K in Q3 2017. 160 funds tracked by Wall St. Rank hold CLVS as of Q2 2021.

  • Pacer Advisors reported no remaining Clovis Oncology, Inc. position as of Q2 2021 after selling out during the quarter.
  • Pacer Advisors sold 13,131 Clovis Oncology, Inc. shares in Q2 2021, an estimated $92K.
  • Pacer Advisors first reported a position in Clovis Oncology, Inc. in Q3 2017 and held it in 6 quarters.
  • Pacer Advisors's Clovis Oncology, Inc. position peaked at $642K in Q3 2017.
  • 160 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2021.

Based on Pacer Advisors's 13F filing for Q2 2021, filed 21 Jul 2021.